The Company    |   Technology & Products   |   Investor Relations   |   Press Room   |   Contact Us   |  Privacy Policy
 

18 Aug 2008
Pluristem Therapeutics to Present at the Noble Financial Equity Conference

11 Aug 2008
Pluristem's PLX-MS Shows Potential Benefit in the Prevention of Multiple Sclerosis

06 Aug 2008
Pluristem Therapeutics Announces $1.6 Million Securities Offering

04 Aug 2008
> Pluristem Appoints Ms. Chaya Mazouz Clinical Operations Director

29 Jul 2008
The Esteemed Dr. Brian Annex Accepts Pluristem's Invitation to Join its Scientific Advisory Board

17 Jul 2008
Pluristem's PLX-BMT Product Featured in the Journal ''Expert Opinion on Biological Therapy''

25 Jun 2008
Pluristem Certified as a Good Manufacturing Practices (GMP) Site for the Manufacture of PLX cells for its Clinical Trials

23 Jun 2008
Pluristem's President & CEO to be Keynote Speaker at The 4th Annual Stem Cells Asia Congress

16 Jun 2008
Pluristem to Exhibit and Present at the BIO International Convention

28 May 2008
Pluristem Demonstrates the Potential of Its PLX Cells to Treat Crohn's Disease and Ulcerative Colitis
19 May 2008
Pluristem to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
15 May 2008
Pluristem to be Featured on RedChip's Real Radio(TM) Show Broadcast
15 May 2008
Pluristem Announces Removal of Restrictive Legends on Shares of Restricted Common Stock According to May 2007 Private Placement Agreement

06 May 2008
FDA and the Paul Ehrlich Institute (Germany) Approve Pluristem's Regulatory Submissions in Support of a Phase I/II Clinical Trial Utilizing PLX-PAD for Peripheral Artery Disease

 

For more News


bioLOGIC Europe

16-19 September 2008

Crowne Plaza Hotel

Geneva, Switzerland

For more Information

 
Copyright © 2008 Pluristem Therapeutics Inc. All rights reserved Design by Mootag